ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
102 hedge funds and large institutions have $128M invested in Antares Pharma, Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
21% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 33
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
Holders
102
Holding in Top 10
1
Calls
$117K
Puts
$112K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$1.96M | |
| 3 | +$1.1M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$857K |
| 5 |
JPMorgan Chase & Co
New York
|
+$831K |
Top Sellers
| 1 | -$7.45M | |
| 2 | -$1.19M | |
| 3 | -$439K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$292K |
| 5 |
Morgan Stanley
New York
|
-$284K |